After a stretch in private practice, Bernstein landed a job with the FTC in 1970, where she impressed Pitofsky by bringing a case against a razor-blade company distributing samples in a newspaper's Sunday comics section.
The significant attraction to companies producing glucose monitoring devices is that the business model is a classic razor-and-blade concept as an overwhelming portion of sales by these companies consists of the recurring test strips.